Oxitec Launched Sparks™, a Commercial Platform to Scale Dengue-Blocking Wolbachia Solution, Aiming to Protect One Billion People by 2040
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
On Dec. 3, 2023, the Bill & Melinda Gates Foundation announced that global donors at COP28 had pledged…
On Oct. 11, 2023, the European Commission, the European Investment Bank and the Bill & Melinda Gates Foundation…
On Feb. 22, 2021, Biohaven Pharmaceutical announced that a hyperimmune globulin mimic (HGM) developed with Biohaven’s proprietary MATE…
On Feb. 17, 2021, Novartis announced that it had entered into a grant agreement with the Bill &…
On Nov. 12, 2020, the Bill & Melinda Gates Foundation announced new commitments totaling $70 million to global…
On Oct. 30, 2020, Icosavax announced the launch of the companyメs COVID-19 vaccine program with preclinical data on…
On Oct. 19, 2020, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics had received a grant…
On Oct. 8, 2020, Eli Lilly and the Bill & Melinda Gates Foundation, as part of the COVID-19…
On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…
On Sept. 28, 2020, the World Health Organization announced agreements to make available, for low and middle-income countries,…
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
On Jul. 8, 2020, Kleo Pharmaceuticals announced that it had received a $5 million grant from the Bill…
On Jun. 23, 2020, INOVIO announced it had received $71 million funding from the U.S. Department of Defense…
On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…
On May 8, 2020, the CoVIg-19 Plasma Alliance was announced, an unprecedented partnership of the world’s leading plasma…
On Apr. 30, 2020, FUJIFILM announced that it will reserve manufacturing capacity for a future COVID-19 therapy for…
On Apr. 16, 2020, Scripps Research announced that researchers at Calibr, Scripp’s drug development division, had established an…
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
On Mar. 30, 2020, the La Jolla Institute for Immunology (LJI) announced it had been awarded a $1.73…
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 10, 2020, the Bill & Melinda Gates Foundation, Wellcome, and Mastercard committed up to $125 million…
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
On Jan. 26, 2020, the Bill & Melinda Gates Foundation announced that it had immediately committed $10 million…
On Dec. 19, 2019, the WHO announced that PNEUMOSIL, a vaccine against a leading cause of deadly childhood…
On Sept. 6, 2017, PATH announced it has received a $120 million grant from the Bill & Melinda…
On Jan. 25, 2017, the Bill & Melinda Gates Foundation pledged $279 million to the University of Washington’s…
On Oct. 25, 2016, the University of Washington’s Population Health Initiative received a $210 million gift from the…